ClinicalTrials.gov
public full text
Public Domain
Tamoxifen in Treatment of Acute Mania
Objective: Evidence indicates that the protein kinase C-PKC signaling cascade may be one of the direct targets in treatment of mania. The aim of this study is to investigate whether the PKC inhibitor-tamoxifen has anti-manic properties. Method: Bipolar subjects with manic/mixed episode were randomly assigned to receive either tamoxifen (80mg/day) or identical placebo tablets in 1:1 ratio for three weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder#903955
- Reconceptualizing bipolar disorder through an integrative biological lens: synthesis, convergence, and emerging directions.#412289
- Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas#1031565
- Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil#1114774
- Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder#279623
Record · ID 918068
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive